Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 70.

Broicher, Sarah D; Filli, Linard; Geisseler, Olivia; Germann, Nicole; Zörner, Björn; Brugger, P; Linnebank, M (2018). Positive effects of fampridine on cognition, fatigue and depression in patients with multiple sclerosis over 2 years. Journal of Neurology, 265(5):1016-1025.

Geisseler, O; Pflugshaupt, T; Bezzola, L; Reuter, K; Weller, D; Schuknecht, B; Brugger, P; Linnebank, M (2016). The relevance of cortical lesions in patients with multiple sclerosis. BMC Neurology, 16(1):204.

Grigoriadis, N; Linnebank, M; Alexandri, N; Muehl, S; Hofbauer, G F (2016). Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion. Expert Opinion on Pharmacotherapy, 17(15):2085-2095.

Oikonomidi, A; Lewczuk, P; Kornhuber, J; Smulders, Y; Linnebank, M; Semmler, A; Popp, J (2016). Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta. Journal of Neurochemistry, 139(2):324-332.

Pflugshaupt, T; Geisseler, O; Nyffeler, T; Linnebank, M (2016). Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment. Seminars in Neurology, 36(2):203-211.

Zörner, B; Filli, L; Reuter, K; Kapitza, S; Lörincz, L; Sutter, T; Weller, D; Farkas, M; Easthope, C S; Czaplinski, A; Weller, M; Linnebank, M (2016). Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern. Multiple Sclerosis, 22(11):1463-1475.

Pflugshaupt, T; Nösberger, M; Gutbrod, K; Weber, K P; Linnebank, M; Brugger, P (2016). Bottom-up Visual Integration in the Medial Parietal Lobe. Cerebral Cortex, 26(3):943-949.

Pfender, N; Linnebank, M; Sommerauer, M; Tarnutzer, A A (2015). Neurosyphilis presenting as a new onset lateralized movement disorder. Journal of Clinical Neuroscience, 22(10):1682-1683.

Semmler, A; Heese, P; Stoffel-Wagner, B; Muschler, M; Heberlein, A; Bigler, L; Prost, J C; Frieling, H; Kornhuber, J; Banger, M; Bleich, S; Hillemacher, T; Linnebank, M (2015). Alcohol abuse and cigarette smoking are associated with global DNA hypermethylation: results from the German Investigation on Neurobiology in Alcoholism (GINA). Alcohol, 49(2):97-101.

Ulrich, A; Müller, D; Linnebank, M; Tarnutzer, A A (2015). Pitfalls in the diagnostic evaluation of subacute combined degeneration. BMJ Case Reports, 2015:online.

Haertle, M; Kallweit, U; Weller, M; Linnebank, M (2014). The presence of oligoclonal IgG bands in human CSF during the course of neurological diseases. Journal of Neurology:554-560.

Semmler, A; Garber, Samuel J; Moskau, S; Frisch, C; Eter, N; Schlegel, U; Linnebank, M (2013). An efficient method for fractionated whole rodent brain radiation. Neurological Research, 35(4):355-359.

Harrer, A; Tumani, H; Niendorf, S; Lauda, F; Geis, C; Weishaupt, A; Kleinschnitz, C; Rauer, S; Kuhle, J; Stangel, M; Weber, F; Uhr, M; Linnebank, M; Wildemann, B; Jarius, S; Guger, M; Ayzenberg, I; Chan, A; Zettl, U; Wiendl, H; Pilz, G; Hitzl, W; Weber, J; Kraus, J (2013). Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy. Multiple Sclerosis Journal, 19(9):1209-1212.

Schaub, C; Uebachs, M; Beck, H; Linnebank, M (2013). Chronic homocysteine exposure causes changes in the intrinsic electrophysiological properties of cultured hippocampal neurons. Experimental Brain Research, 225(4):527-534.

Kallweit, U; Aritake, K; Bassetti, C L; Blumenthal, S; Hayaishi, O; Linnebank, M; Baumann, C R; Urade, Y (2013). Elevated CSF histamine levels in multiple sclerosis patients. Fluids and Barriers of the CNS, 10:19.

Kallweit, U; Baumann, C R; Harzheim, M; Hidalgo, H; Pöhlau, D; Bassetti, C L; Linnebank, M; Valko, P O (2013). Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association? Multiple Sclerosis International, 2013:286581.

Semmler, A; Moskau-Hartmann, S; Stoffel-Wagner, B; Elger, C E; Linnebank, M (2013). Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism. Clinical Chemistry and Laboratory Medicine, 51(3):665-669.

Farkas, M; Keskitalo, S; Smith, D E C; Bain, N; Semmler, A; Ineichen, B; Smulders, Y; Blom, H; Kulic, L; Linnebank, M (2013). Hyperhomocysteinemia in Alzheimer's disease: The hen and the egg? Journal of Alzheimer's disease : JAD, 33(4):1097-1104.

Ramirez, J O; Cabrera, S A S; Hidalgo, H; Cabrera, S G; Linnebank, M; Bassetti, C L; Kallweit, U (2013). Is preeclampsia associated with restless legs syndrome? Sleep Medicine, 14(9):894-896.

Schippling, S; Kempf, C; Büchele, F; Jelcic, I; Bozinov, O; Bont, A; Linnebank, M; Sospedra, M; Weller, M; Budka, H; Martin, R (2013). JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment. Annals of Neurology, 74(4):622-626.

Semmler, A; Prost, J C; Smulders, Y; Smith, D; Blom, H; Bigler, L; Linnebank, M (2013). Methylation metabolism in sepsis and systemic inflammatory response syndrome. Scandinavian Journal of Clinical and Laboratory Investigation, 73(5):368-372.

Schreglmann, S R; Jelčić, I; Taegtmeyer, A B; Linnebank, M; Weller, M (2013). Multifocal CNS demyelination after octreotide treatment for metastatic meningioma. Clinical Neurology and Neurosurgery, 115(6):817-819.

Preiningerova, J L; Baumhackl, U; Csepany, T; Czaplinski, A; Deisenhammer, F; Derfuss, T; Fabjan, T H; Fazekas, F; Fuchs, S; Havrdova, E; Ledinek, A H; Illes, Z; Jazbec, S S; Klimova, E; Komoly, S; Kurca, E; Linnebank, M; Lisy, L; Mares, J; Prochazkova, L; Csilla, R; Szilasiova, J; Stourac, P; Talab, R; Turcani, P; Vachova, M; Vecsei, L; Vodusek, D; Zapletalova, O; Berger, T (2013). Recommendations for the use of prolonged-release fampridine in patients with multiple sclerosis (MS). Cns Neuroscience & Therapeutics, 19(5):302-306.

Gobbi, C; Zecca, C; Linnebank, M; Müller, S; You, X; Meier, R; Borter, E; Traber, M (2013). Swiss analysis of multiple sclerosis: a multicenter, non-interventional, retrospective cohort study of disease-modifying therapies. European Neurology, 70(1-2):35-41.

Linnebank, M; Moskau, S; Semmler, A; Hoefgen, B; Bopp, G; Kallweit, U; Maier, W; Schütz, C G; Wüllner, U (2012). A possible genetic link between MTHFR genotype and smoking behavior. PLoS ONE, 7(12):e53322.

Heese, P; Linnebank, M; Semmler, A; Muschler, M A N; Heberlein, A; Frieling, H; Stoffel-Wagner, B; Kornhuber, J; Banger, M; Bleich, S; Hillemacher, T (2012). Alterations of homocysteine serum levels during alcohol withdrawal are influenced by folate and riboflavin: Results from the German investigation on neurobiology in alcoholism (GINA). Alcohol and Alcoholism, 47(5):497-500.

Linnebank, M; Moskau, S; Semmler, A; Widman, G; Weller, M; Kallweit, U; Elger, C E (2012). Antiepileptic drugs and vitamin B6 plasma levels in adult patients. Epilepsy Research, 101(1-2):182-184.

Linnebank, M; Moskau, S; Kowoll, A; Semmler, A; Bangard, C; Vogt-Schaden, M; Egerer, G; Schackert, G; Reichmann, H; Schmidt-Wolf, I G H; Pels, H; Schlegel, U (2012). Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma. British Journal of Cancer:1-4.

Petersen, J A; Jung, H H; Weller, M; Linnebank, M (2012). Autoimmune myasthenia gravis after sternal fracture. Case Reports in Neurology, 4(1):20-22.

Smith, D E C; Smulders, Y M; Blom, H J; Popp, J; Jessen, F; Semmler, A; Farkas, M; Linnebank, M (2012). Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid. Clinical Chemistry and Laboratory Medicine, 50(9):1641-1647.

Arlt, S; Schwedhelm, E; Kölsch, H; Jahn, H; Linnebank, M; Smulders, Y; Jessen, F; Böger, R H; Popp, J (2012). Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer's disease. Journal of Alzheimer's Disease, 31(4):751-758.

Wittmann, M; Dewald, D; Urbach, H; Gast, A S; Linnebank, M; Baumgarten, G; Knuefermann, P; Hering, R (2012). Sinus venous thrombosis: a differential diagnosis of postpartum headache. Archives of Gynecology and Obstetrics, 285(1):93-97.

Kallweit, U; Jelcic, I; Braun, N; Fischer, H; Zörner, B; Schreiner, B; Sokolov, A A; Martin, R; Weller, M; Linnebank, M (2012). Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a Swiss cohort. Clinical Neuropharmacology, 35(2):77-80.

Semmler, A; Frisch, C; Smith, D; Blom, H; Linnebank, M (2012). The ratio of S-adenosylmethione and S-adenosyl-homocysteine is increased in the brains of newborn rats in a model of valproic acid teratogenicity. Toxicology, 293(1-3):132-133.

Kühnlein, P; Jung, H H; Farkas, M; Keskitalo, S; Ineichen, B; Jelcic, I; Petersen, J; Semmler, A; Weller, M; Ludolph, A C; Linnebank, M (2011). The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is a possible risk factor for amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 12(2):136-139.

Linnebank, M; Moskau, S; Semmler, A; Widman, G; Stoffel-Wagner, B; Weller, M; Elger, C E (2011). Antiepileptic drugs interact with folate and vitamin B12 serum levels. Annals of Neurology, 69(2):352-359.

Aly, L; Yousefi, S; Schippling, S; Jelcic, I; Breiden, P; Matschke, J; Schulz, R; Bofill-Mas, S; Jones, L; Demina, V; Linnebank, M; Ogg, G; Girones, R; Weber, T; Sospedra, M; Martin, R (2011). Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. Brain: A Journal of Neurology, 134(Pt 9):2687-2702.

Petersen, J A; Linnebank, M (2011). Clinical and biological aspects of thiamine deficiency. In: Hermann, W; Obeid, R. Vitamins in the prevention of human diseases. Berlin: de Gruyter, 52-61.

Holmes, M V; Newcombe, P; Hubacek, J A; Sofat, R; Ricketts, S L; Cooper, J; Breteler, M M; Bautista, L E; Sharma, P; Whittaker, J C; Smeeth, L; Fowkes, F G; Algra, A; Shmeleva, V; Szolnoki, Z; Roest, M; Linnebank, M; Zacho, J; Nalls, M A; Singleton, A B; Ferrucci, L; Hardy, J; Worrall, B B; Rich, S S; Matarin, M; Norman, P E; Flicker, L; Almeida, O P; van Bockxmeer, F M; Shimokata, H; Khaw, K T; Wareham, N J; Bobak, M; Sterne, J A C; Smith, G D; Talmud, P J; van Duijn, C; Humphries, S E; Price, J F; Ebrahim, S; Lawlor, D A; Hankey, G J; Meschia, J F; Sandhu, M S; Hingorani, A D; Casas, J P (2011). Effect modification by population dietary folate on the association between MTHFR genotype, homocysteine, and stroke risk: a meta-analysis of genetic studies and randomised trials. Lancet, 378(9791):584-594.

Semmler, A; Moskau, S; Lutz, H; Meyer, P; Linnebank, M (2011). Haplotype analysis of the 5,10-methylenetetrahydrofolate reductase (MTHFR) c.1298A>C (E429A) polymorphism. BMC Research Notes, 4:439.

Patrij, K; Reiser, M; Wätzel, L; Pels, H; Kowoll, A; Herrlinger, U; Engert, A; Linnebank, M; Schackert, G; Vogt-Schaden, M; Egerer, G; Lamprecht, M; Batchelor, T T; Schlegel, U; Schmidt-Wolf, I G H (2011). Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis. German Medical Science, 9:Doc11.

Bernhart-Just, A; Kunkel, S; Linnebank, M; Staudacher, D; Spirig, R (2011). Kompetenzzentrum für Patienten mit Multipler Sklerose.Ein zukunftsorientiertes Versorgungsmodell. Krankenpflege, 104(10):15-17.

Conzett, K B; Kolm, I; Jelcic, I; Kamarachev, J; Dummer, R; Braun, R P; French, L E; Linnebank, M; Hofbauer, G F (2011). Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report. Archives of Dermatology, 147(8):991-992.

Moskau, S; Smolka, K; Semmler, A; Schweichel, D; Harbrecht, U; Müller, J; Pohl, C; Klockgether, T; Linnebank, M (2010). Common genetic coagulation variants are not associated with ischemic stroke in a casecontrol study. Neurological Research, 32(5):519-522.

Ackermann, R; Semmler, A; Maurer, G D; Hattingen, E; Fornoff, F; Steinbach, J P; Linnebank, M (2010). Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolites. Journal of Neuro-Oncology, 97(3):425-427.

Klotz, L; Farkas, M; Bain, N; Keskitalo, S; Semmler, A; Ineichen, B; Jelcic, J; Klockgether, T; Kösch, H; Weller, M; Linnebank, M (2010). The variant methylenetetrahydrofolate reductase c.1298A > C (p.E429A) is associated with multiple sclerosis in a German case-control study. Neuroscience Letters, 468(3):183-185.

Hofer, S; Linnebank, M; Weller, M; Bahmanyar, S; Montgomery, S M; Hillert, J; Ekbom, A; Olsson, T (2010). Cancer risk among patients with multiple sclerosis and their parents. Neurology, 74(7):614-615; author reply 615.

Tamagni, C; Mondadori, C R A; Valko, P O; Brugger, P; Schuknecht, B; Linnebank, M (2010). Cerebellum and source memory. European Neurology, 63(4):234-236.

Riederer, F; Sándor, P S; Linnebank, M; Ettlin, Dominik A (2010). Familial occipital and nervus intermedius neuralgia in a Swiss family. Journal of Headache and Pain, 11(4):335-338.

Kurzwelly, D; Knop, S; Guenther, M; Loeffler, J; Korfel, A; Thiel, E; Hebart, H; Simon, M; Weller, M; Linnebank, M; Herrlinger, U (2010). Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population. Journal of Neuro-Oncology, 100(2):187-192.

Juergens, A; Pels, H; Rogowski, S; Fliessbach, K; Glasmacher, A; Engert, A; Reiser, M; Diehl, V; Vogt-Schaden, M; Egerer, G; Schackert, G; Reichmann, H; Kroschinsky, F; Bode, U; Herrlinger, U; Linnebank, M; Deckert, M; Fimmers, R; Schmidt-Wolf, I G H; Schlegel, U (2010). Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Annals of Neurology, 67(2):182-189.

Semmler, A; Moskau, S; Grigull, A; Farmand, S; Klockgether, T; Smulders, Y; Blom, H; Zur, B; Stoffel-Wagner, B; Linnebank, M (2010). Plasma folate levels are associated with the lipoprotein profile: a retrospective database analysis. Nutrition Journal, 9:31.

Linnebank, M; Popp, J; Smulders, Y; Smith, D; Semmler, A; Farkas, M; Kulic, L; Cvetanovska, G; Blom, H; Stoffel-Wagner, B; Kölsch, H; Weller, M; Jessen, F (2010). S-Adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegenerative Diseases, 7(6):373-378.

Semmler, A; Farmand, S; Moskau, S; Stoffel-Wagner, B; Linnebank, M (2010). The G allele of transcobalamin 2 c.776C→G is associated with an unfavorable lipoprotein profile. Annals of Nutrition & Metabolism, 57(2):112-115.

Shete, S; Hosking, F J; Robertson, L B; Dobbins, S E; Sanson, M; Malmer, B; Simon, M; Marie, Y; Boisselier, B; Delattre, J Y; Hoang-Xuan, K; El Hallani, S; Idbaih, A; Zelenika, D; Andersson, U; Henriksson, R; Bergenheim, A T; Feychting, M; Lönn, S; Ahlbom, A; Schramm, J; Linnebank, M; Hemminki, K; Kumar, R; Hepworth, S J; Price, A; Armstrong, G; Liu, Y; Gu, X; Yu, R; Lau, C; Schoemaker, M; Muir, K; Swerdlow, A; Lathrop, M; Bondy, M; Houlston, R S (2009). Genome-wide association study identifies five susceptibility loci for glioma. Nature Genetics, 41(8):899-904.

Linnebank, M; Moskau, S; Jurgens, A; Simon, M; Semmler, A; Orlopp, K; Glasmacher, A; Bargart, C; Vogt-Schaden, M; Urbach, H; Schmidt-Wolf, I G; Pels, H; Schlegel, U (2009). Association of genetic variants of methionine metabolism with methotrexate-induced CNS white matter changes in patients with primary CNS lymphoma. Neuro-Oncology, 11(1):2-8.

Pels, H; Juergens, A; Glasmacher, A; Schulz, H; Engert, A; Linnebank, M; Schackert, G; Reichmann, H; Kroschinsky, F; Vogt-Schaden, M; Egerer, G; Bode, U; Schaller, C; Lamprecht, M; Hau, P; Deckert, M; Fimmers, R; Bangard, C; Schmidt-Wolf, G; Schlegel, U (2009). Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study. Journal of Neuro-Oncology, 91(3):299-305.

Rakovic, A; Stiller, B; Djarmati, A; Flaquer, A; Freudenberg, J; Toliat, M R; Linnebank, M; Kostic, V; Lohmann, K; Paus, S; Nürnberg, P; Kubisch, C; Klein, C; Wüllner, U; Ramirez, A (2009). Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease. Movement Disorders, 24(3):429-433.

Lenz, B; Soehngen, C; Linnebank, M; Heberlein, A; Frieling, H; Kornhuber, J; Hillemacher, T; Bleich, S (2009). Genetic polymorphisms relevant for one-carbon metabolism show no effect on homocysteine plasma levels and DNA methylation in alcoholism. Psychiatric Genetics, 19(4):215-216.

Semmler, A; Bao, X; Cao, G; Köhler, W; Weller, M; Aubourg, P; Linnebank, M (2009). Genetic variants of methionine metabolism and X-ALD phenotype generation: results of a new study sample. Journal of Neurology, 256(8):1277-1280.

Popp, J; Lewczuk, P; Linnebank, M; Cvetanovska, G; Smulders, Y; Kölsch, H; Frommann, I; Kornhuber, J; Maier, W; Jessen, F (2009). Homocysteine metabolism and CSF markers for Alzheimer's disease. Journal of Alzheimer's Disease, 5(4 / Su):500.

Moskau, S; Semmler, A; Stoffel-Wagner, B; Linnebank, M (2009). Plasma homocysteine levels after acute stroke and in the convalescent phase. Canadian Journal of Neurological Sciences, 36(6):789-790.

Häberle, J; Pauli, S; Berning, C; Koch, H G; Linnebank, M (2009). TC II deficiency: avoidance of false-negative molecular genetics by RNA-based investigations. Journal of Human Genetics, 54(6):331-334.

Semmler, A; Moskau, S; Stoffel-Wagner, B; Weller, M; Linnebank, M (2009). The effect of MTHFR c.677C>T on plasma homocysteine levels depends on health, age and smoking. Clinical and Investigative Medicine, 32(6):E310-E314.

Linnebank, M. Zur Bedeutung des Homocystein-Stoffwechsels für zerebrovaskuläre, neuroonkologische und neurodegenerative Erkrankungen. 2009, University of Zurich, Faculty of Medicine.

Kurzwelly, D; Müller, C A; Korfel, A; Thiel, E; Linnebank, M; Weller, M; Herrlinger, U (2008). Primary CNS lymphoma and HLA class I and II alleles in a German cohort of immunocompetent patients. Journal of Neuro-Oncology, 90(1):53-55.

Semmler, A; Köhler, W; Jung, H H; Weller, M; Linnebank, M (2008). Therapy of X-linked adrenoleukodystrophy. Expert Review of Neurotherapeutics, 8(9):1367-1379.

Hillemacher, T; Frieling, H; Moskau, S; Muschler, M A N; Semmler, A; Kornhuber, J; Klockgether, T; Bleich, S; Linnebank, M (2008). Global DNA methylation is influenced by smoking behaviour. European Neuropsychopharmacology, 18(4):295-298.

Semmler, A; Smulders, Y; Struys, E; Smith, D; Moskau, S; Blom, H; Linnebank, M (2008). Methionine metabolism in an animal model of sepsis. Clinical Chemistry and Laboratory Medicine, 46(10):1398-1402.

Linnebank, M; Semmler, A; Moskau, S; Smulders, Y; Blom, H; Simon, M (2008). The methylenetetrahydrofolate reductase (MTHFR) variant c.677C>T (A222V) influences overall survival of patients with glioblastoma multiforme. Neuro-Oncology, 10(4):548-552.

This list was generated on Tue Jun 18 14:37:14 2019 CEST.